Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes

MLA

Jiwon Park, et al. “Cardiometabolic Benefits of Fenofibrate in Heart Failure Related to Obesity and Diabetes.” Cardiovascular Diabetology, vol. 23, no. 1, Sept. 2024, pp. 1–17. EBSCOhost, https://doi.org/10.1186/s12933-024-02417-6.

APA

Jiwon Park, Hangyul Song, Shinje Moon, Yumin Kim, Sungsoo Cho, Kyungdo Han, Cheol-Young Park, Sung Woo Cho, & Chang-Myung Oh. (2024). Cardiometabolic benefits of fenofibrate in heart failure related to obesity and diabetes. Cardiovascular Diabetology, 23(1), 1–17. https://doi.org/10.1186/s12933-024-02417-6

Chicago

Jiwon Park, Hangyul Song, Shinje Moon, Yumin Kim, Sungsoo Cho, Kyungdo Han, Cheol-Young Park, Sung Woo Cho, and Chang-Myung Oh. 2024. “Cardiometabolic Benefits of Fenofibrate in Heart Failure Related to Obesity and Diabetes.” Cardiovascular Diabetology 23 (1): 1–17. doi:10.1186/s12933-024-02417-6.